Authors:
PRINSSEN HM
MOLTHOFF CFM
VERHEIJEN RHM
BROADHEAD TJ
KENEMANS P
ROOS JC
DAVIES Q
VANHOF AC
FRIER M
DENHOLLANDER W
WILHELM AJ
BAKER TS
SOPWITH M
SYMONDS EM
PERKINS AC
Citation: Hm. Prinssen et al., BIODISTRIBUTION OF IN-111-LABELED ENGINEERED HUMAN-ANTIBODY CTM01 (HCTM01) IN OVARIAN-CANCER PATIENTS - INFLUENCE OF PRIOR ADMINISTRATION OF UNLABELED HCTM01, Cancer immunology and immunotherapy, 47(1), 1998, pp. 39-46
Authors:
MOLTHOFF CFM
PRINSSEN HM
KENEMANS P
VANHOF AC
DENHOLLANDER W
VERHEIJEN RHM
Citation: Cfm. Molthoff et al., ESCALATING PROTEIN DOSES OF CHIMERIC MONOCLONAL-ANTIBODY MOV18 IMMUNOGLOBULIN-G IN OVARIAN-CARCINOMA PATIENTS - A PHASE-I STUDY, Cancer, 80(12), 1997, pp. 2712-2720
Citation: Cw. Burger et al., LHRH AGONIST TREATMENT OF BREAST-CANCER AND GYNECOLOGICAL MALIGNANCIES - A REVIEW, European journal of obstetrics, gynecology, and reproductive biology, 67(1), 1996, pp. 27-33